IABP and pVADs: Clinical Effectiveness Versus Cost

No comments

invasivecardiology

By Atman P. Shah, MD, FACC, FSCAI
Clinical Director, Section of Cardiology
Co-Director, Cardiac Catheterization Laboratory
Associate Professor of Medicine
The University of Chicago

Interventional cardiologists are increasingly able to take care of complex coronary artery disease in a population of patients that would have be been deemed too high-risk a decade ago. However, many of these patients have poor left ventricular function and may need to undergo prolonged ischemic times during percutaneous revascularization. There are a number of support devices available for interventional cardiologists to use, and given that every single patient is different, it is up to the operator to personalize therapy within the construct of available data. But, the available data are not entirely clear and do not seem to clearly favor one device over another. Given the changing economics of health care, if there is no clear winning device, should cost influence a physician’s decision? The…

View original post 134 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s